Beam Therapeutics CFO Terry-Ann Burrell resigns; CEO John Evans named interim principal financial officer

Beam Therapeutics Inc.

CFO Terry-Ann Burrell resigns effective Aug 9, 2024 to join JPMorgan as vice chairman of investment banking.
CEO John Evans appointed Principal Financial and Accounting Officer upon her departure, continuing as CEO.
Company initiates search for a permanent CFO successor.
Burrell had served as CFO for 5 years, overseeing IPO and capital raising efforts.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

John Evans

Principal Financial and Accounting Officer

BEAM · Beam Therapeutics Inc.

Effective: 2024-08-09
Filed: July 15, 2024, 7:59 PM ET

Effective upon Ms. Burrell’s resignation, John Evans, the Company’s Chief Executive Officer and a member of the Company’s board of directors, was appointed Principal Financial and Accounting Officer of the Company.

Departed (interim)

Terry-Ann Burrell

Chief Financial Officer and Treasurer

BEAM · Beam Therapeutics Inc.

Effective: 2024-08-09
Successor: John Evans
Filed: July 15, 2024, 7:59 PM ET

Terry-Ann Burrell notified Beam Therapeutics Inc. (the “Company”) of her decision to resign as Chief Financial Officer and Treasurer of the Company, effective August 9, 2024, to pursue other opportunities.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Evans was appointed as Principal Financial and Accounting Officer at Beam Therapeutics Inc..

Action: appointed
Role: Principal Financial and Accounting Officer

Exact text from the filing

Effective upon Ms. Burrell’s resignation, John Evans, the Company’s Chief Executive Officer and a member of the Company’s board of directors, was appointed Principal Financial and Accounting Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Terry-Ann Burrell resigned as Chief Financial Officer and Treasurer at Beam Therapeutics Inc..

Action: resigned
Role: Chief Financial Officer and Treasurer

Exact text from the filing

Terry-Ann Burrell notified Beam Therapeutics Inc. (the “Company”) of her decision to resign as Chief Financial Officer and Treasurer of the Company, effective August 9, 2024, to pursue other opportunities.

View on SEC.gov

Beam Therapeutics Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-178824

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.